Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.
E SignorielloM FoschiR LanzilloJ FrauE CoccoG BorrielloA IannielloM TrottaD LandiG T ManiscalcoF RuscicaS ToscanoF PattiA ZanghìE D'AmicoR FantozziD CentonzeG LusSimona BonavitaPublished in: Journal of neurology (2024)
Our findings suggest that pregnancy does not appear to influence disease activity and disability in women previously treated with cladribine; further studies with larger numbers and longer follow-up are needed to confirm this finding.
Keyphrases
- disease activity
- multiple sclerosis
- rheumatoid arthritis
- systemic lupus erythematosus
- pregnancy outcomes
- rheumatoid arthritis patients
- ankylosing spondylitis
- preterm birth
- juvenile idiopathic arthritis
- polycystic ovary syndrome
- pregnant women
- type diabetes
- newly diagnosed
- insulin resistance
- case control
- breast cancer risk